Moderna founder launches Apriori with $50M to stay ahead of virus variants - BioPharma Dive

Flagship Pioneering’s latest startup aims to use predictive technology to find “variant-proof” treatments and vaccines for infectious diseases before they might be needed.

Dive Brief:

• Flagship Pioneering, a creator of new biotech companies and founder of COVID-19 vaccine maker Moderna, announced Monday the launch of an infectious disease startup called Apriori… [+2251 chars]
  full article...